{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:04:35Z","timestamp":1773770675304,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Kawasaki disease (KD) is an acute and febrile systemic vasculitis that occurs during childhood. Infliximab (IFX) is a chimeric monoclonal antibody that binds to tumor necrosis factor-\u03b1. Although IFX therapy is a useful option for refractory KD, vaccine-associated infections may develop after therapy. In Japan, IFX therapy is recommended after a duration of at least 3 months after live vaccinations or at least 6 months after Bacillus Calmette-Gu\u00e9rin (BCG) in children with KD. However, the appropriate duration between live vaccinations and IFX therapy is unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We investigated children who developed KD within 3 months after live vaccinations or within 6 months after BCG. Clinical characteristics, side effects of therapies and efficacy of live vaccinations were retrospectively investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Forty-eight patients developed KD within 3 months of live vaccinations or within 6 months after BCG. Eight patients underwent IFX therapy. There were no apparent vaccine-associated infections. The patients who underwent IFX acquired protective IgG antibody titers in the 5 of 6 live vaccines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Safe and appropriate duration between live vaccinations and IFX therapy for KD patients could be shorter in the future, although more studies are warranted to establish the safe duration.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003611","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:18:35Z","timestamp":1658967515000},"page":"e388-e392","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Safety and Feasibility of Infliximab Therapy in Children With Kawasaki Disease Who Received Live Vaccinations"],"prefix":"10.1097","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7109-476X","authenticated-orcid":false,"given":"Yuji","family":"Ohnishi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kawakami-Miyake","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Furuta","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiji","family":"Fukano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yasudo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Shimokawa","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.jacc.2015.12.073","article-title":"Kawasaki disease.","volume":"67","author":"Newburger","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/archdischild-2014-306427","article-title":"Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous \u03b3-immunoglobulin therapy.","volume":"100","author":"Lin","year":"2015","journal-title":"Arch Dis Child"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00006454-199812000-00009","article-title":"Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki Syndrome Study Group.","volume":"17","author":"Burns","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome.","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2249.2005.02821.x","article-title":"Immunological profile of peripheral blood lymphocytes and monocytes\/macrophages in Kawasaki disease.","volume":"141","author":"Matsubara","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/INF.0000000000002503","article-title":"Real-world safety and effectiveness of infliximab in pediatric patients with acute kawasaki disease: a postmarketing surveillance in Japan (SAKURA Study).","volume":"39","author":"Miura","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn\u2019s disease.","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohns Colitis"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/INF.0000000000001447","article-title":"Safety of infliximab following live virus vaccination in Kawasaki Disease Patients.","volume":"36","author":"Lee","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1442-200x.2005.02033.x","article-title":"Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition).","volume":"47","author":"Ayusawa","year":"2005","journal-title":"Pediatr Int"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00431-012-1891-5","article-title":"Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis.","volume":"172","author":"Ha","year":"2013","journal-title":"Eur J Pediatr"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","article-title":"JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki Disease.","volume":"84","author":"Fukazawa","year":"2020","journal-title":"Circ J"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/jcm10091816","article-title":"Screening for TB in hospitalised patients with inflammatory bowel disease before Anti-TNF Therapy: is QuantiFERON\u00ae Gold Testing Useful?","volume":"10","author":"Lovatt","year":"2021","journal-title":"J Clin Med"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3947\/ic.2019.51.3.310","article-title":"Successful treatment of fulminant hepatitis due to varicella zoster virus using immunoglobulin in a kidney transplant patient.","volume":"51","author":"Hsing","year":"2019","journal-title":"Infect Chemother"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1097\/MPH.0b013e3181ec0efb","article-title":"Use of intravenous immunoglobulin in a disseminated varicella infection in an immunocompromised child.","volume":"33","author":"Lu","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis.","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"Suppl 3","key":"R22-20250614","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/14397595.2014.969916","article-title":"Pediatric Rheumatology Association of Japan recommendation for vaccination in pediatric rheumatic diseases.","volume":"25","author":"Kobayashi","year":"2015","journal-title":"Mod Rheumatol"},{"key":"R24-20250614","first-page":"593","article-title":"Immunogenicity of high dose influenza vaccine for patients with inflammatory bowel disease on Anti-TNF monotherapy: a randomized clinical trial.","volume":"26","author":"Caldera","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.vaccine.2015.06.086","article-title":"Long-term safety and efficacy of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy.","volume":"33","author":"Toplak","year":"2015","journal-title":"Vaccine"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MPG.0b013e3181bab351","article-title":"Varicella vaccination in children with inflammatory bowel disease receiving immunomodulators.","volume":"50","author":"Lu","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:09:38Z","timestamp":1749946178000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003611","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,27]]}}}